1. Home
  2. SLNO vs IBOC Comparison

SLNO vs IBOC Comparison

Compare SLNO & IBOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • IBOC
  • Stock Information
  • Founded
  • SLNO 1999
  • IBOC 1966
  • Country
  • SLNO United States
  • IBOC United States
  • Employees
  • SLNO N/A
  • IBOC N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • IBOC Major Banks
  • Sector
  • SLNO Health Care
  • IBOC Finance
  • Exchange
  • SLNO Nasdaq
  • IBOC Nasdaq
  • Market Cap
  • SLNO 3.7B
  • IBOC 4.2B
  • IPO Year
  • SLNO 2014
  • IBOC N/A
  • Fundamental
  • Price
  • SLNO $46.98
  • IBOC $67.25
  • Analyst Decision
  • SLNO Strong Buy
  • IBOC
  • Analyst Count
  • SLNO 9
  • IBOC 0
  • Target Price
  • SLNO $114.89
  • IBOC N/A
  • AVG Volume (30 Days)
  • SLNO 2.2M
  • IBOC 240.1K
  • Earning Date
  • SLNO 11-04-2025
  • IBOC 11-06-2025
  • Dividend Yield
  • SLNO N/A
  • IBOC 2.08%
  • EPS Growth
  • SLNO N/A
  • IBOC 5.13
  • EPS
  • SLNO N/A
  • IBOC 6.76
  • Revenue
  • SLNO $98,675,000.00
  • IBOC $821,716,000.00
  • Revenue This Year
  • SLNO N/A
  • IBOC N/A
  • Revenue Next Year
  • SLNO $181.30
  • IBOC N/A
  • P/E Ratio
  • SLNO N/A
  • IBOC $9.94
  • Revenue Growth
  • SLNO N/A
  • IBOC 2.80
  • 52 Week Low
  • SLNO $41.50
  • IBOC $54.11
  • 52 Week High
  • SLNO $90.32
  • IBOC $76.91
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 31.94
  • IBOC 48.13
  • Support Level
  • SLNO $66.12
  • IBOC $64.65
  • Resistance Level
  • SLNO $69.99
  • IBOC $69.63
  • Average True Range (ATR)
  • SLNO 3.71
  • IBOC 1.42
  • MACD
  • SLNO -2.47
  • IBOC 0.18
  • Stochastic Oscillator
  • SLNO 18.57
  • IBOC 52.21

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About IBOC International Bancshares Corporation

International Bancshares Corp is a multibank financial holding company. The company provides commercial and retail banking services in Texas and Oklahoma. The services provided by the bank include checking, savings, bank cards, lending, insurance, mortgage, investments, and other services.

Share on Social Networks: